DAFNA Capital Management as of June 30, 2019
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 87 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Stereotaxis (STXS) | 14.9 | $40M | 14M | 2.90 | |
| Sage Therapeutics (SAGE) | 8.5 | $23M | 124k | 183.09 | |
| Blueprint Medicines (BPMC) | 4.4 | $12M | 123k | 94.33 | |
| AtriCure (ATRC) | 3.6 | $9.5M | 319k | 29.84 | |
| Alder Biopharmaceuticals | 2.8 | $7.5M | 636k | 11.77 | |
| Ascendis Pharma A S Sponsored Adr (ASND) | 2.6 | $6.8M | 59k | 115.16 | |
| Galapagos Nv Spon Adr (GLPG) | 2.5 | $6.8M | 53k | 128.93 | |
| Zogenix Com New | 2.5 | $6.7M | 141k | 47.78 | |
| Ishares Tr Nasdaq Biotech Etf (IBB) | 2.5 | $6.7M | 61k | 109.10 | |
| Aerie Pharmaceuticals | 2.3 | $6.1M | 205k | 29.55 | |
| Wave Life Sciences SHS (WVE) | 2.1 | $5.7M | 218k | 26.09 | |
| Arena Pharmaceuticals Com New | 2.1 | $5.5M | 94k | 58.63 | |
| ArQule | 2.1 | $5.5M | 498k | 11.01 | |
| Neurocrine Biosciences (NBIX) | 2.1 | $5.5M | 65k | 84.43 | |
| Dex (DXCM) | 2.0 | $5.4M | 36k | 149.84 | |
| Cytokinetics Com New (CYTK) | 2.0 | $5.4M | 477k | 11.25 | |
| Argenx Se Sponsored Adr (ARGX) | 1.7 | $4.5M | 32k | 141.57 | |
| Cara Therapeutics (CARA) | 1.7 | $4.4M | 205k | 21.50 | |
| Biohaven Pharmaceutical Holding | 1.6 | $4.2M | 95k | 43.79 | |
| Akebia Therapeutics (AKBA) | 1.5 | $4.0M | 831k | 4.84 | |
| Luminex Corporation | 1.5 | $4.0M | 194k | 20.64 | |
| Eloxx Pharmaceuticals | 1.4 | $3.7M | 375k | 9.97 | |
| Radius Health Note 3.000% 9/0 (Principal) | 1.4 | $3.6M | 4.0M | 0.91 | |
| Menlo Therapeutics | 1.4 | $3.6M | 600k | 5.99 | |
| Xenon Pharmaceuticals (XENE) | 1.2 | $3.3M | 331k | 9.86 | |
| Bluebird Bio (BLUE) | 1.2 | $3.2M | 26k | 127.22 | |
| Genocea Biosciences Com New (GNCAQ) | 1.1 | $2.9M | 734k | 3.92 | |
| Cortexyme (QNCX) | 1.0 | $2.8M | 65k | 42.51 | |
| Phasebio Pharmaceuticals | 1.0 | $2.6M | 200k | 13.12 | |
| Cymabay Therapeutics | 0.9 | $2.5M | 350k | 7.16 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 0.9 | $2.4M | 262k | 9.10 | |
| Translate Bio | 0.8 | $2.3M | 178k | 12.63 | |
| Cardiovascular Systems | 0.8 | $2.2M | 51k | 42.93 | |
| Biotelemetry | 0.8 | $2.2M | 45k | 48.15 | |
| Epizyme | 0.8 | $2.2M | 174k | 12.55 | |
| Corbus Pharmaceuticals Hldgs | 0.8 | $2.1M | 297k | 6.93 | |
| Accuray Incorporated (ARAY) | 0.8 | $2.0M | 524k | 3.87 | |
| Foamix Pharmaceuticals SHS | 0.7 | $1.9M | 808k | 2.38 | |
| Dicerna Pharmaceuticals | 0.7 | $1.9M | 118k | 15.75 | |
| Ardelyx (ARDX) | 0.7 | $1.8M | 682k | 2.69 | |
| Kadmon Hldgs | 0.7 | $1.8M | 886k | 2.06 | |
| Intec Pharma Ltd Jerusalem SHS | 0.7 | $1.8M | 416k | 4.34 | |
| Viking Therapeutics (VKTX) | 0.7 | $1.7M | 209k | 8.30 | |
| Nevro (NVRO) | 0.6 | $1.7M | 26k | 64.82 | |
| Scynexis | 0.6 | $1.7M | 1.3M | 1.31 | |
| Achillion Pharmaceuticals | 0.6 | $1.6M | 605k | 2.68 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.6 | $1.6M | 100k | 16.10 | |
| BioCryst Pharmaceuticals (BCRX) | 0.6 | $1.6M | 411k | 3.79 | |
| Inogen (INGN) | 0.6 | $1.5M | 23k | 66.74 | |
| Nextcure (NXTC) | 0.5 | $1.4M | 96k | 14.98 | |
| Gamida Cell SHS | 0.5 | $1.4M | 275k | 5.08 | |
| Applied Genetic Technol Corp C | 0.5 | $1.4M | 359k | 3.79 | |
| Johnson & Johnson (JNJ) | 0.5 | $1.3M | 9.4k | 139.26 | |
| Fate Therapeutics (FATE) | 0.5 | $1.2M | 60k | 20.31 | |
| Morphic Hldg (MORF) | 0.4 | $1.2M | 60k | 19.82 | |
| Mersana Therapeutics (MRSN) | 0.4 | $1.1M | 275k | 4.05 | |
| Natus Medical | 0.4 | $1.1M | 43k | 25.69 | |
| Dermira | 0.4 | $994k | 104k | 9.56 | |
| Prevail Therapeutics Ord | 0.4 | $990k | 75k | 13.20 | |
| Kura Oncology (KURA) | 0.3 | $930k | 47k | 19.69 | |
| Macrogenics (MGNX) | 0.3 | $849k | 50k | 16.98 | |
| Spero Therapeutics (SPRO) | 0.3 | $806k | 70k | 11.51 | |
| Insmed Com Par $.01 (INSM) | 0.3 | $768k | 30k | 25.60 | |
| Madrigal Pharmaceuticals (MDGL) | 0.3 | $692k | 6.6k | 104.85 | |
| Assembly Biosciences | 0.3 | $682k | 51k | 13.49 | |
| Obseva Sa | 0.2 | $564k | 50k | 11.31 | |
| Gritstone Oncology Ord (GRTS) | 0.2 | $557k | 50k | 11.14 | |
| Kalvista Pharmaceuticals (KALV) | 0.2 | $548k | 25k | 22.16 | |
| Urogen Pharma (URGN) | 0.2 | $539k | 15k | 35.93 | |
| Radius Health Com New | 0.2 | $536k | 22k | 24.36 | |
| Masimo Corporation (MASI) | 0.2 | $446k | 3.0k | 148.67 | |
| Alector (ALEC) | 0.2 | $440k | 23k | 18.99 | |
| Dexcom Note 0.750% 5/1 (Principal) | 0.1 | $399k | 250k | 1.60 | |
| Rigel Pharmaceuticals Com New | 0.1 | $359k | 138k | 2.61 | |
| Sutro Biopharma (STRO) | 0.1 | $358k | 32k | 11.37 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.1 | $357k | 213k | 1.68 | |
| Zafgen | 0.1 | $340k | 286k | 1.19 | |
| Sol Gel Technologies SHS (SLGL) | 0.1 | $319k | 35k | 9.11 | |
| Aldeyra Therapeutics (ALDX) | 0.1 | $300k | 50k | 6.00 | |
| Alder Biopharmaceuticals Note 2.500% 2/0 (Principal) | 0.1 | $232k | 250k | 0.93 | |
| Karuna Therapeutics Ord | 0.1 | $200k | 10k | 20.00 | |
| BioTime | 0.0 | $105k | 95k | 1.11 | |
| Ngm Biopharmaceuticals | 0.0 | $92k | 6.3k | 14.68 | |
| Aileron Therapeutics | 0.0 | $72k | 100k | 0.72 | |
| Oramed Pharmaceuticals Com New (ORMP) | 0.0 | $57k | 16k | 3.56 | |
| Bellicum Pharma | 0.0 | $51k | 30k | 1.70 | |
| Arcturus Therapeutics Hldg I (ARCT) | 0.0 | $23k | 2.4k | 9.58 |
